OrthoPediatrics Corp (KIDS) stock
Close on Nov 17, 2026Market cap $820.13MP/E –Yield –
OrthoPediatrics Corp grew revenue 16.1% to $264.14M over the twelve months to Sep 30, 2026. Free cash flow was $3.18M. At the latest close the market valued the company at $820.13M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $820.13M
- P/E ratio
- –
- Price to sales
- 3.10
- Price to book
- 2.42
- Dividend yield
- –
- Free cash flow yield
- 0.39%
Fundamentals
- Revenue
- $264.14M
- Net income
- -$33.88M
- EPS, diluted
- -$1.43
- Free cash flow
- $3.18M
- Book value per share
- $14.05
- Diluted shares
- 24M
Trading
- Next earnings
- Feb 25, 2027 (estimated, during market hours)
- Previous close
- $31.50
- Open
- $31.34
- Day's range
- $30.99 – $32.04
- Volume
- 172,044
- Average volume (20 days)
- 442,239
- Index membership
- Russell 2000, Russell 3000
- 52-week range
- $14.42 – $34.53
- RSI (14 days)
- 60.4
- Volatility (1 year)
- 52.2%
- Relative volume
- 0.66×
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2017, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 17, 2026. The S&P 500 is measured by the SPY fund.
| Period | KIDS | S&P 500 | Difference | KIDS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +43.1% | -4.0% | +47.1 pts | ||
| 3 months | +27.2% | -5.0% | +32.1 pts | ||
| Year to date | +76.9% | +8.2% | +68.6 pts | ||
| 1 year | +92.5% | +11.2% | +81.2 pts | ||
| 3 years | +0.6% | +68.5% | −67.8 pts | +0.2% | +19.0% |
| 5 years | -51.3% | +67.3% | −118.6 pts | -13.4% | +10.8% |
| 10 years | +62720.0% | +291.6% | +62428.4 pts | +90.5% | +14.6% |
Twelve years at a glance
Fiscal years 2014 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases OrthoPediatrics filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Results
- Update
- Results
About OrthoPediatrics
Surgical & Medical Instruments & Apparatus
OrthoPediatrics Corp. is a medical device company that develops, manufactures, and markets anatomically appropriate implants, surgical instruments, and specialized bracing products for children with orthopedic conditions. The company also provides non-surgical clinical care through a network of orthotic and prosthetic clinics. Its offerings address three primary categories: trauma and deformity correction, scoliosis, and sports medicine. OrthoPediatrics designs its systems to accommodate pediatric anatomy and protect children's growth plates, serving pediatric orthopedic surgeons, caregivers, and pediatric hospitals.
Company profile, executives and historyOrthoPediatrics stock: common questions
What is OrthoPediatrics's stock price?
KIDS closed at $31.41 on Nov 17, 2026, down 0.29% on the day. Over the past 52 weeks it traded between $14.42 and $34.53.
What is OrthoPediatrics's market cap?
OrthoPediatrics was worth $820.13M at the close on Nov 17, 2026: the share price times the diluted shares outstanding.
What is KIDS's P/E ratio?
OrthoPediatrics lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.43), so it has no meaningful P/E ratio.
How much revenue does OrthoPediatrics make?
OrthoPediatrics reported revenue of $264.14M for the twelve months to Sep 30, 2026, up 16.1% from a year earlier.
Does OrthoPediatrics pay a dividend?
No. OrthoPediatrics has not paid a cash dividend over the last twelve months.
When does OrthoPediatrics report earnings next?
OrthoPediatrics is expected to report Q4 FY2026 results on Feb 25, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has KIDS stock performed over the past year?
Including dividends, KIDS returned +92.5% over the past year, against +11.2% for the S&P 500.
How many KIDS shares are sold short?
1M shares were sold short at the latest FINRA report, 4.12% of the float, or 1.5 days of average trading volume.
Who are OrthoPediatrics's competitors?
Companies most similar to OrthoPediatrics by business, industry and size include SIBN, LMAT, BVS, OFIX, XTNT.
See a number that looks wrong?